Application of amlodipine and cephalosporin medicines to preparation of medicine-resistant combined antibiotics

A technology of amlodipine and cephalosporins, applied in the field of medicine and biology, can solve the problems of long development cycle and high cost of research and development of new antibiotics

Active Publication Date: 2018-06-08
易子越
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment of positive drug-resistant bacteria can rely on new β-lactam antibiotics; however, in the short term, drug-resistant bacteria will adapt to new antibiotics again, and the development cost of new antibiotics is high and the development cycle is long

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of amlodipine and cephalosporin medicines to preparation of medicine-resistant combined antibiotics
  • Application of amlodipine and cephalosporin medicines to preparation of medicine-resistant combined antibiotics
  • Application of amlodipine and cephalosporin medicines to preparation of medicine-resistant combined antibiotics

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0088] Experimental principle and method

[0089] 1. Bacterial culture

[0090] 2. Test the inhibition sensitivity of bacteria to different drugs, combinations and concentrations

[0091] 3. Compare the bacterial inhibition sensitivity of various single drugs and benzsulfonic acid. The bacterial inhibition sensitivity of amlodipine combined with various corresponding drugs

[0092] 4. Using 96-well bacterial culture plate, absorbance test, (partial) bacterial activity staining

[0093] Experimental drug materials

[0094] MRSA

[0095] 1. Resistant Staphylococcus aureus strains

[0096] The strains are derived from specimens submitted for clinical examination, and obtained after purification through bacterial identification and drug sensitivity screening. The test result of the Mérieux appraiser VITEK2 is 99%, and the biocode: 010402062763231 (the appraisal result is attached)

[0097] 2. Benzenesulfonic acid. Amlodipine (B / A)

[0098] The sample used in the experiment is a white powder of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medical biology, and particularly relates to application of amlodipine and cephalosporin medicines to preparation of medicine-resistant combined antibiotics. After computational biology indicates that amlodipine has an inhibitory effect on beta-lactam hydrolase, medicine testing is performed by using MRSA and acinetobacter bauamnnii as models, and through combination with cephalosporin antibiotics, a relatively good bacteriostatic effect on the MRSA is achieved; novel application is provided for the amlodipine, and a novel medicinal composition is provided for positive medicine-resistant bacteria; other more effective combinations containing the amlodipine can be further developed; the conventional cephalosporin and amlodipine combinations are mature in technology, few in side effects and low in cost; and the amlodipine and cephalosporin medicines can be applied to preparation of the medicine-resistant combined antibiotics, preparation ofbeta-lactam medicine-resistant bacterium inhibiting combined antibiotics and preparation of medicines for treating respiratory infection, wound infection and infection caused by all positive bacteria.

Description

One technical field [0001] The invention belongs to the field of medical biotechnology, and specifically relates to the application of amlodipine and cephalosporins in the preparation of anti-drug resistance combined antibiotics. 2. Background technology [0002] With the abuse of antibiotics, multi-drug-resistant bacteria have emerged all over the world, including MRSA and Acinetobacter baumannii. This type of bacteria occurs mostly in places where antibiotics are abused such as hospitals. Because multi-drug resistant bacteria are resistant to drugs, the mortality rate is relatively high; on the other hand, bacteria adapt to new antibiotics faster than antibiotic development. The treatment of positive drug-resistant bacteria can rely on new β-lactam antibiotics; however, drug-resistant bacteria will adapt to new antibiotics again in the short term, and the development cost of new antibiotics is high and the development cycle is long. [0003] In addition to new antibiotics, comb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4422A61K45/06A61K31/546A61P31/04A61P11/00A61P17/02
CPCA61K31/4422A61K31/546A61K45/06A61K2300/00
Inventor 易子越
Owner 易子越
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap